Keyword Index for Volume 110

ABCB1 1673 acceleration 2217 accreditation 850 actinic keratosis 520 active surveillance 2405 activin signalling 2604 acute myeloid leukaemia 783 ADAM9 2945 ADAMs 1535 adaptive design 1950 ADCC 1221 adenocarcinoma 1571, 2688 adherence 831 adhesion 146, 753 adjuvant chemotherapy 313 adjuvant therapy 1133, 1545 adolescent 1342 advanced adenoma 1228 advanced biliary tract cancer 2165 advanced neoplasia 1334 aerobic exercise 831 AFP 2090 AFP-L3 2090 age 1125 aggressiveness 1767 Akt 399, 935, 946, 1785, 1288, 2081 Akt signalling 899 albumin 2090, 2277 alcohol 242 aldehyde dehydrogenase 3A1 2593 ALDH1 430 ALDH1A1 protein 2935 aldo-keto reductase 1C3 1506 alkylating agents 2623 allergy 1825 alpha9 1269 alpha-fetoprotein 2277 amino-acid transporter 2030 amoeboid phenotype 2099 amphiregulin 648 amplification 2914 androgen receptor gene amplification 1655 aneuploidy 2159 angiogenesis 26, 107, 115, 469, 741, 946, 1027, 1034, 1179, 1269, 2700 angiogenic cytokines 441 animal welfare 928 anoikis 958 anti-angiogenesis 602, 882 anticipated delay 12 anti-inflammatory agents 1409 anti-oncomir 189 antitumour activity 1733 anti-tumour immunity 83 anxiety 868 APOBEC3 2615 apoptosis 63, 164, 341, 421, 656, 753, 1645, 2144, 2224 apoptosis and cytotoxicity 146 appetite loss 1409 aromatase inhibitors 1133 ascites fluid 2269 ASCT2 2030, 2506 Asian 2187 aspirin 2378 atopy 1825 autoimmune disease 1825 autophagy 899, 2209 awareness 12 axitinib 875, 2821